FellowshipInvesting in the future of neuroscience and neurotechnology.

Kaleida Capital is an early-stage venture capital firm based in San Diego, California, specializing in neurotechnology and artificial intelligence. The firm invests in companies developing brain-inspired technologies, including neural engineering and brain-computer interfaces.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Kaleida Capital is an investment organization founded by Dr. Ariane Tom, focusing on neurotechnology and artificial intelligence. Based in the United States, the firm aims to support the development of brain-inspired technologies that enhance human abilities and enable precision medicine. Kaleida Capital invests in early-stage companies, particularly in areas such as neural data infrastructure, human performance, and digital interfaces. The firm emphasizes technical diligence and scientific fluency, backing visionary founders who are developing innovative solutions in the neurotechnology sector.
Kaleida Capital primarily invests in the neurotechnology and AI sectors, concentrating on areas such as neural data infrastructure, human performance, and digital interfaces. The firm targets early-stage companies that are developing transformative technologies in neural engineering and brain-computer interfaces, with a commitment to fostering innovation that has a significant impact on human health and capabilities.
Kaleida Capital adds value to its portfolio companies through deep technical diligence, scientific expertise, and a strong network in the neurotechnology and AI sectors. The firm supports founders with research-driven IP and clear clinical or commercial pathways, providing guidance and resources to help navigate the complexities of developing advanced technologies.
Kaleida Capital focuses on early-stage companies in the neurotechnology and AI sectors. They look for startups that are developing breakthrough technologies, particularly in neural engineering and brain-computer interfaces.
Founders can submit their pitches through the Kaleida Capital website. It is recommended to include a detailed overview of the technology, market potential, and team background in the pitch deck.
Kaleida Capital specializes in neurotechnology and AI, providing not only capital but also expertise in these fields. Their team comprises professionals with deep knowledge and experience, which can be invaluable for portfolio companies.
The firm primarily invests in companies based in the United States, aligning with their goal to support local innovations in neurotechnology and AI.
Kaleida Capital invests at various early stages, including pre-seed, seed, seed-plus, and Series A, with check sizes that are appropriate for these stages.
Kaleida Capital engages actively with its portfolio companies, offering mentorship and operational support to help them scale effectively.
Superscout Pro
Is this page right?Reviewed · How the research works